+ +

•  

   

     Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Jurkat cells, Primary antibody: P05308(SLC39A9 Antibody) at dilution 1/200, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1 minute    

  
  

The SLC39A9 antibody is a research tool designed to detect and study the solute carrier family 39 member 9 (SLC39A9), a zinc transporter protein also known as ZIP9. Belonging to the SLC39/ZIP family, SLC39A9 facilitates cellular zinc uptake from extracellular spaces or intracellular organelles, playing a critical role in maintaining zinc homeostasis. Zinc, an essential micronutrient, is involved in numerous biological processes, including enzymatic activity, immune regulation, and cell signaling. Dysregulation of SLC39A9 has been linked to pathologies such as cancer progression, neurodegenerative disorders, and metabolic diseases, making it a target for mechanistic and therapeutic studies.

SLC39A9 antibodies are typically developed as monoclonal or polyclonal reagents, validated for applications like Western blotting, immunohistochemistry (IHC), immunofluorescence (IF), or flow cytometry. These antibodies enable researchers to investigate protein expression levels, subcellular localization (e.g., plasma membrane, endosomes), and tissue-specific distribution. High-quality antibodies are often verified using knockout cell lines or siRNA-mediated silencing to confirm specificity, given the structural similarities among ZIP transporters. However, challenges remain, including potential cross-reactivity with related proteins or variability due to post-translational modifications.

Recent studies highlight SLC39A9's role in cancer metastasis, Alzheimer’s disease, and hormonal signaling, underscoring the antibody's utility in both basic research and translational medicine. Its application extends to exploring zinc's impact on cellular proliferation, apoptosis, and immune responses, offering insights into disease mechanisms and therapeutic targeting.